Boston Scientific stock holds near its yearly low after downgrade
Published on 09/22/2026 at 10:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Boston Scientific stock closed at USD 43.72 on the NYSE on September 21, 2026, up USD 0.38, or 0.88 percent, from the prior session. The price was USD 1.52 above the 52-week low of USD 42.20 and far below the 52-week high of USD 105.65, making valuation and execution the central issues for Boston Scientific Corporation (ISIN US10117L1017).
Citigroup cuts its target
According to Yahoo Finance on September 17, 2026, Citigroup downgraded the shares to Neutral and lowered its price target from USD 57 to USD 50. The revised target remains USD 6.28 above the September 21 closing price, but the cut removes part of the valuation cushion implied by the former target.
The same Yahoo Finance analyst data show an average target of USD 61.76, with a range from USD 44.00 to USD 94.00. At USD 43.72, the stock therefore traded USD 0.28 below the lowest published target in that overview, a concrete sign that the market price had moved ahead of the most cautious target.
Quarterly numbers remain substantial
Boston Scientific reported second-quarter fiscal 2026 revenue of USD 5.44 billion and earnings of USD 907 million, according to the quarterly data displayed by Yahoo Finance. The reported second-quarter EPS of USD 0.86 exceeded the displayed estimate of USD 0.83 by USD 0.03, while the listed profit margin was 16.67 percent.
The comparison matters because the share-price weakness is not matched by a quarterly earnings miss in the available Q2 fiscal 2026 figures. Trailing twelve-month revenue was listed at USD 21 billion, with revenue growth of 13.53 percent and EBITDA growth of 18.41 percent, although those trailing figures combine several reporting periods and should not be confused with a single quarter.
Stock remains near its low
The September 21 session produced a range of USD 42.72 to USD 43.81 on volume of 24,423,389 shares. Market capitalization stood at USD 63.36 billion as of that close, while the 52-week range of USD 42.20 to USD 105.65 places the closing price close to the lower boundary rather than the midpoint.
The next listed earnings date is October 28, 2026. Until then, the clearest numerical tension is between the Q2 fiscal 2026 EPS beat of USD 0.03 and Citigroup's reduced USD 50 target, with the stock at USD 43.72 on September 21, 2026.
Boston Scientific stock closes at USD 43.72
Boston Scientific stock closed at USD 43.72 in USD on the NYSE on September 21, 2026, with a daily gain of 0.88 percent and a market capitalization of USD 63.36 billion.
Boston Scientific stock at a glance
- Company: Boston Scientific Corporation
- ISIN: US10117L1017
- Ticker: BSX
- Trading venue: NYSE
- Price as of September 21, 2026: USD 43.72
- Market capitalization: USD 63.36 billion as of September 21, 2026
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: October 28, 2026
